Innoviva
INVA
234 hedge funds and large institutions have $1.13B invested in Innoviva in 2019 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 84 increasing their positions, 76 reducing their positions, and 36 closing their positions.
193% more call options, than puts
Call options by funds: $12.4M | Put options by funds: $4.23M
11% more repeat investments, than reductions
Existing positions increased: 84 | Existing positions reduced: 76
6% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 36
0% more funds holding
Funds holding: 233 → 234 (+1)
0.41% more ownership
Funds ownership: 79.22% → 79.63% (+0.41%)
18% less capital invested
Capital invested by funds: $1.38B → $1.13B (-$245M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| 1 |
SCM
Sarissa Capital Management
Greenwich,
Connecticut
|
+$15.8M |
| 2 |
1M
13D Management
New York
|
+$9.93M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$8.89M |
| 4 |
JIM
Jupiter Investment Management
London,
United Kingdom
|
+$8.03M |
| 5 |
AC
Antara Capital
New York
|
+$6.48M |
Top Sellers
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$10.9M |
| 2 |
PCM
Penserra Capital Management
Orinda,
California
|
-$10.9M |
| 3 |
First Eagle Investment Management
New York
|
-$7.77M |
| 4 |
ACA
Ackerman Capital Advisors
Dallas,
Texas
|
-$5.89M |
| 5 |
Millennium Management
New York
|
-$5.67M |
INVA Hedge Fund Activity: Q1 2019 in Review
234 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Innoviva (INVA) for Q1 2019, worth a combined $1.13B — down 18% from $1.38B a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new INVA positions and 36 closed out — a net gain of 2 holders — while 84 added to existing stakes and 76 trimmed.
The largest buyer was Sarissa Capital Management, adding an estimated $15.8M. The largest seller was Deutsche Bank, cutting an estimated $10.9M.
- 234 institutional investors held Innoviva (INVA) as of Q1 2019, up from 233 in Q4 2018.
- Funds reported $1.13B of Innoviva stock for Q1 2019, down 18% quarter-over-quarter.
- 38 funds opened new Innoviva positions in Q1 2019 and 36 closed out, a net change of +2 holders.
- The largest Innoviva buyer in Q1 2019 was Sarissa Capital Management, an estimated $15.8M added.
- The largest Innoviva seller in Q1 2019 was Deutsche Bank, an estimated $10.9M sold.
Based on aggregated 13F filings for Q1 2019.